tiprankstipranks
Trending News
More News >
Tvardi Therapeutics (TVRD)
NASDAQ:TVRD

Tvardi Therapeutics (TVRD) Similar Stocks

Compare
2,534 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Tvardi Therapeutics
$3.89
$37.06M
-0.39
-73.57%
3 Buy
4 Hold
0 Sell
Moderate Buy
Plus Therapeutics
$0.58
$79.71M
-0.29
-44.34%
3 Buy
0 Hold
0 Sell
Strong Buy
Cue Biopharma
$0.34
$31.50M
-0.75
-66.47%
Aligos Therapeutics
$10.37
$65.41M
-0.52
-72.96%
2 Buy
0 Hold
0 Sell
Moderate Buy
Genenta Science SpA Sponsored ADR
$1.48
$26.61M
-2.90
-72.39%
0 Buy
0 Hold
0 Sell
Moderate Buy
Adlai Nortye Ltd. Sponsored ADR
$1.64
$60.89M
-27.57%
0 Buy
1 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
TVRD
Tvardi Therapeutics
3.89
-11.32
-74.42%
PSTV
Plus Therapeutics
0.55
-0.54
-49.54%
CUE
Cue Biopharma
0.34
-0.67
-66.34%
ALGS
Aligos Therapeutics
10.37
-29.47
-73.97%
GNTA
Genenta Science SpA Sponsored ADR
1.48
-3.53
-70.46%
ANL
Adlai Nortye Ltd. Sponsored ADR
1.55
-0.61
-28.24%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts